Literature DB >> 220834

Demyelinating encephalomyelitis induced by a long-term corona virus infection in rats. A preliminary report.

K Nagashima, H Wege, R Meyermann, V ter Meulen.   

Abstract

About 30% of weanling rats inoculated with JHM virus developed a subacute demyelinating encephalomyelitis (SDE) 3 weeks after inoculation (a.i.). From the remaining animals, 5% displayed overt neurological signs 3, 6, and 8 months a.i. Animals with and without clinical signs 6-8 months a.i. were morphologically examined. Fresh demyelinating lesions could be demonstrated in paralyzed animals. Viral antigen was demonstrated and infectious JHM virus could be recovered from one animal which developed clinical signs at 3 months a.i. In one animal with clinical onset of 8 months a.i. completely remyelinated areas as well as recent demyelinating lesions were observed, suggesting a recurrence of the disease process. Remyelinated areas were also found in 40% of clinically silent animals. The morphology of the late onset of the demyelination was similar to that occurring in SDE. Remyelination consisted of both CNS and PNS-type. This animal model offers the possibility to investigate the virus-host relationship which is responsible for the induction of a demyelinating process after a long incubation period.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 220834      PMCID: PMC7086537          DOI: 10.1007/bf00702672

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  18 in total

1.  Schwann cells and regenerated peripheral myelin in multiple sclerosis: an ultrastructural study.

Authors:  J Ogata; I Feigin
Journal:  Neurology       Date:  1975-08       Impact factor: 9.910

2.  Mouse hepatitis virus-induced recurrent demyelination. A preliminary report.

Authors:  R M Herndon; D E Griffin; U McCormick; L P Weiner
Journal:  Arch Neurol       Date:  1975-01

3.  Chronic relapsing experimental allergic encephalomyelitis: an experimental model of multiple sclerosis.

Authors:  H M Wiśniewski; A B Keith
Journal:  Ann Neurol       Date:  1977-02       Impact factor: 10.422

4.  Regeneration of myelin in multiple sclerosis. The role of mesenchymal cells in such regeneration and in myelin formation in the peripheral nervous system.

Authors:  I Feigin; N Popoff
Journal:  Neurology       Date:  1966-04       Impact factor: 9.910

5.  Pattern of remyelination in the CNS.

Authors:  W F Blakemore
Journal:  Nature       Date:  1974-06-07       Impact factor: 49.962

6.  Remyelination in multiple sclerosis with peripheral type myelin.

Authors:  N R Ghatak; A Hirano; Y Doron; H M Zimmerman
Journal:  Arch Neurol       Date:  1973-10

7.  An ultrastructural study of experimental demyelination and remyelination. 3. Chronic experimental allergic encephalomyelitis in the central nervous system.

Authors:  J Prineas; C S Raine; H Wísniewski
Journal:  Lab Invest       Date:  1969-12       Impact factor: 5.662

8.  Remyelination by Schwann cells of axons demyelinated by intraspinal injection of 6-aminonicotinamide in the rat.

Authors:  W F Blakemore
Journal:  J Neurocytol       Date:  1975-12

9.  Regeneration of oligodendroglia during recovery from demyelinating disease.

Authors:  R M Herndon; D L Price; L P Weiner
Journal:  Science       Date:  1977-02-18       Impact factor: 47.728

10.  The ultrastructural basis of capillary permeability studied with peroxidase as a tracer.

Authors:  M J Karnovsky
Journal:  J Cell Biol       Date:  1967-10       Impact factor: 10.539

View more
  45 in total

1.  The pathogenic role of virus-specific antibody-secreting cells in the central nervous system of rats with different susceptibility to coronavirus-induced demyelinating encephalitis.

Authors:  S Schwender; H Imrich; R Dörries
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

2.  Characterization of mouse hepatitis virus-specific cytotoxic T cells derived from the central nervous system of mice infected with the JHM strain.

Authors:  S A Stohlman; S Kyuwa; J M Polo; D Brady; M M Lai; C C Bergmann
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

3.  Analysis of age-dependent resistance to murine coronavirus JHM infection in mice.

Authors:  K Pickel; M A Müller; V ter Meulen
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

4.  Selected mutants of mouse hepatitis virus type 4 (JHM strain) induce different CNS diseases. Pathobiology of disease induced by wild type and mutants ts8 and ts15 in BALB/c and SJL/J mice.

Authors:  R L Knobler; L A Tunison; P W Lampert; M B Oldstone
Journal:  Am J Pathol       Date:  1982-11       Impact factor: 4.307

5.  Influence of maternal immunity on the outcome of murine coronavirus JHM infection in suckling mice.

Authors:  K Pickel; M A Müller; V ter Meulen
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

6.  Coronavirus JHM-induced demyelinating encephalomyelitis in rats: influence of immunity on the course of disease.

Authors:  H Wege; R Watanabe; M Koga; V Ter Meulen
Journal:  Prog Brain Res       Date:  1983       Impact factor: 2.453

7.  In vivo and in vitro models of demyelinating disease: endogenous factors influencing demyelinating disease caused by mouse hepatitis virus in rats and mice.

Authors:  O Sorensen; R Dugre; D Percy; S Dales
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

8.  Infection by coronavirus JHM of rat neurons and oligodendrocyte-type-2 astrocyte lineage cells during distinct developmental stages.

Authors:  J M Pasick; S Dales
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

9.  In vivo and in vitro models of demyelinating disease. IX. Progression of JHM virus infection in the central nervous system of the rat during overt and asymptomatic phases.

Authors:  O Sorensen; M B Coulter-Mackie; S Puchalski; S Dales
Journal:  Virology       Date:  1984-09       Impact factor: 3.616

10.  Coronavirus JHM: cell-free synthesis of structural protein p60.

Authors:  S G Siddell; H Wege; A Barthel; V ter Meulen
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.